Medizinische Universität Graz - Research portal
Skofler Christina |
Presentations at scientific and public conferences
Bonstingl, L; Zinnegger, M; Sallinger, K; Skofler, C; Ulz, C; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Abuja, PM; Oberauner-Wappis, L; Kühberger, S; Moser, T; Heitzer, E; Bauernhofer, T; Kroneis, T; El-Heliebi, A;
A Liquid biopsy multi-analyte approach deciphering treatment resistance in prostate cancer supported by machine learning
EACR Liquid Biopsy; NOV 12-14, 2024; Lyon, FRANCE. 2024.
[Poster]
Bonstingl, L; Zinnegger, M; Sallinger, K; Skofler, C; Ulz, C; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Abuja, PM; Oberauner-Wappis, L; Moser, T; Heitzer, E; Bauernhofer, T; Kroneis, T; El-Heliebi, A;
Longitudinal tracking of drug resistance in metastatic prostate cancer
Circulating Nucleic Acids in Plasma and Serum (CNAPS); MAR 4-6, 2024; Graz, AUSTRIA. 2024.
[Poster]
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Zinnegger, M; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Bauernhofer, T; Kroneis, T; El-Heliebi, A
Characterization of circulating tumor cells by combinatorial dual-color (CoDuCo) in situ padlock probe hybridization and supervised machine-learning.
Applications of In Situ Hybridisation and Spatial Profiling Methods in Research and Disease; MAY 16-17, 2023; Cambridge, UK. 2023.
[Poster]
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Zinnegger, M; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Bauernhofer, T; Kroneis, T; El-Heliebi, A
CTC characterization by multiplex mRNA in situ hybridization and machine learning-assisted classification for longitudinal monitoring of drug resistance in metastatic prostate cancer.
6th ACTC Advances in Circulating Tumor Cells; SEP 20-23, 2023; Skiathos, GREECE. 2023.
[Poster]
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Zinnegger, M; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Herbsthofer, L; Bauernhofer, T; Kroneis, T; El-Heliebi, A
Spotting the difference: rare cell characterization by multiplex mRNA in situ hybridization and machine learning in the context of liquid biopsy-based therapy resistance monitoring.
13th International Symposium on Minimal Residual Cancer ISMRC; MAY 2-4, 2023; Hamburg, GERMANY. 2023.
[Poster]
Bonstingl, L; Sallinger, K; Zinnegger, M; Skofler, C; Ulz, C; Pankratz, K; Pritz, E; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Bauernhofer, T; Kroneis, T; El-Heliebi, A
Tracking drug resistance in metastatic prostate cancer: longitudinal CTC characterization using multiplex mRNA in situ hybridization and machine learning-assisted classification.
General Assembly of the European Liquid Biopsy Society ELBS; NOV 9-10, 2023; Rome, ITALY. 2023.
[Oral Communication]
Alcaniz, J; Dahlmann, M; Conrad, T; Orthmann, A; Haybaeck, J; Krassnig, S; Wodlej, C; Birkl-Toeglhofer, AM; Kratzsch, T; Kuhn, SA; Joedicke, A; Iduna, F; Hoffmann, J; Walther, W
Molecular analyses of Glioblastoma patient-derived xenograft (PDX) models identify potential targets in treatment resistant tumors
ONCOL RES TREAT. Abstracts 35. Deutscher Krebskongress. 2022; 45(SUPPL 3):47-47.-35. Deutscher Krebskongress. Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung; NOV 13-16, 2022; Berlin, GERMANY.
[Poster]
Web of Science
El-Heliebi, A; Prietl, B; Mahdy-Ali, K; Purkart, TU; Gerlitz, L; Skofler, C; Stanzer, S; Franz, J; Harbusch, N; Madl, T; Widhalm, G; Rossler, K; Tomberger, M; Mattersdorfer, K; Kroneis, T; Oberhuber, M; Pieber, TR
Next generation drug screening platform: generation of patient-derived cells for ex vivo drug response studies of gliomas
NEURO-ONCOLOGY. 2022; 24: -Brain Tumor Meeting 2022; May 19-20, 2022; Berlin, GERMANY.
Doi: 10.1093/neuonc/noac174.180
[Poster]
Web of Science
FullText
FullText_MUG
El-Heliebi, A; Prietl, B; Mahdy-Ali, K; Purkart, TU; Moazzami, A; Leoni, M; Gerlitz, L; Skofler, C; Stanzer, S; Franz, J; Harbusch, N; Madl, T; Wadiura, L; Peilnsteiner, T; Widhalm, G; Rössler, K; Tomberger, M; Mattersdorfer, K; Her, NG; Nam, DH; Kroneis, T; Oberhuber, M; Pieber, TR
Next generation drug screening platform: generation of patient derived cells for ex vivo drug response studies of gliomas
10.1093/neuonc/noac174.180. 2022; 24(SI):-17th Meeting of the European Association of Neuro-Oncology; SEP 15-18, 2022; Vienna, AUSTRIA.
[Poster]
El-Heliebi, A; Urbanic-Purkart, T; Mahdy-Ali, K; Skofler, C; Gerlitz, L; Stanzer, S; Franz, J; Harbusch, N; Madl, T; Widhalm, G; Rossler, K; Tomberger, M; Mattersdorfer, K; Kroneis, T; Oberhuber, M; Pieber, T; Prietl, B
PATIENT-DERIVED CELLS FOR EX VIVO DRUG SCREENING STUDIES OF GLIOMAS
NEURO-ONCOLOGY. 2022; 24: 209-209.-27th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO); NOV 16-20, 2022; Tampa, FL.
[Poster]
Web of Science
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Oberauner-Wappis, L; Pritz, E; Pankratz, K; Kroneis, T; El-Heliebi, A
A novel workflow to enumerate circulating tumor cells by multiplex in situ padlock probe technology and machine learning-based classification.
EACR Virtual Conference Bioinformatics in Cancer; MAY 18-19, 2021; Nottingham, UK. 2021.
[Poster]
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Pritz, E; Pankratz, K; Gruber, MC; Kroneis, T; El-Heliebi, A
Enumerating circulating tumor cells by multiplex in situ padlock probe technology and machine learning-based classification.
5th ACTC - Advances in Circulating Tumor Cells - Liquid Biopsy in its best; SEP 22-25, 2021; Kalamata, GREECE. 2021.
[Poster]
Leber, S; Krassnig, S; Birkl-Toeglhofer, A; Golob-Schwarzl, N; Wodlej, C; Flunkert, S; Hutter-Paier, B; Kalev, O; Weis, S; Haybaeck, J
Septin2 and 9 Alterations in Human Post mortem Alzheimer’s Disease Brains
Proceedings of The Lancet Summit, 2021. 2021; -The Lancet Summit: Presymptomatic Prevention and Treatment of Neurodegenerative Diseases; Dez 14 - 16, 2021; London (virtual).
[Poster]
Leber, S; Johannes Haybaeck, Stefanie Kraßnig, Anna Töglhofer, Nicole Golob-Schwarzl, Christina Wodlej, Ognian Kalev, Serge Weis, Stephan Sygulla, Marlene Leoni, Stefanie Flunkert, Birgit Hutter-Paier
Septin2 and 9 as contributors to alzheimer's disease
Proceedings of the 4th Joint Annual Meeting of the Swiss and Austrian Societies of Pathology. 2019; -JOINT ANNUAL MEETING SGPATH-ÖGPATH-SSCYT 2019 ; 07 - 09 November 2019 ; Luzern.
[Poster]
Leber SL, Krassnig S, Birkl-Toeglhofer AM, Golob-Shwarzl N, Wodlej C, Llenos IC, Dulay J, Kalev O, Sygulla S, Leoni M, Flunkert S, Hutter-Paier B, Smalla KH, Seidenbecher C, Weis S, Haybaeck J
Septin2 and 9 in Alzeimer´s disease.
Proceedings of the Annual Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN). 2019; -Annual Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN); SEPT 19–21, 2019 ; Magdeburg, GERMANY.
[Oral Communication]
Wodlej, C; Krassnig, S; Kleinegger, F; Birkl-Toeglhofer, AM; Singer, G; Till, H; Benesch, M; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J
Eukaryotic initiation factor 4A1 might represent a novel therapeutic target in neuroblastoma
Virchows Archive. 2019; -103. Jahrestagung der Deutschen Gesellschaft für Pathologie (DGP); JUN 13-15, 2019; Frankfurt am Main, GERMANY.
[Oral Communication]
Baehr, A; Krassnig, S; Schinlauer, A; Nass, N; Golob-Schwarzl, N; Wodlej, C; Raicht, A; Speicher, I; von Campe, G; Asslaber, M; Mawrin, C; Benesch, M; Haybaeck, J.
Eukaryotic initiation factors are differentially expressed in pediatric and adult medulloblastoma.
Neurowoche 2018; 91. Kongress der Deutschen Gesellschaft für Neurologie; OCT 30-NOV 3, 2018; Berlin, GERMANY. 2018.
[Poster]
Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Krassnig, S; Wodlej, C; Gogg-Kamerer, M; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch ,F; Stacher-Priehse ,E; Rolff , J; Hoffmann , J; Silvestri ,A; Regenbrecht ,C; Reinhard, C; Pehserl , AM; Pichler ,M; Sokolova , O; Naumann ,M; Mitterer ,V; Pertschy,B; Bergler, H; Popper, H; Sattler , W; Haybaeck, J
Influence of eukaryotic translation initiation factors in non-small cell lung cancer development and progression
30th European Congress of Pathology, Pathology: Path to Precision medicine; SEP 10, 2018; Bilbao, SPAIN. 2018.
[Poster]
Gantenbein, N; Wodlej, C; Smolle, E; Thalhammer, M; Kornprat, P; Lackner, K; Brcic, I; Spindelbock, W; Kump, P; Lipp, R; Haybaeck, J
Are eIF Ingredients for Neuroendocrine Tumorigenesis?
ENETS. 2018; -ENETS; March 7-9, 2018; Barcelona.
[Poster]
Gantenbein, N; Wodlej, C; Smolle, E; Thalhammer, M; Kornprat, P; Lackner, K; Brcic, I; Spindelboeck, W; Kump, P; Lipp, R; Haybaeck, J
Are eIFs Ingredients for Neuroendocrine Tumorigenesis?
NEUROENDOCRINOLOGY. 2018; 106: 5-5.-15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 07-09, 2018; Barcelona, SPAIN.
[Poster]
Web of Science
Golob-Schwarzl, N; Wodlej, C; Kleinegger, F; Toeglhofer, AM; Krassnig, S; Thalhammer, M; Aigelsreiter, A; Hayback, J
Eukaryotic Translation Initiation Factors Might Represent a Potential Therapeutic Target for Gallbladder Cancer
ONCOL RES TREAT. 2018; 41: 68-68.-33. Deutscher Krebs Kongress; FEB 21-24, 2018; Berlin, GERMANY.
[Poster]
Web of Science
Herzl, A; Krassnig, S; Wodlej, C; Birkl-Toeglhofer, AM; Golob-Schwarzl, N; Kalev, O; Leoni, M; Sygulla, S; Weis, S; Haybaeck, J;
Inhibiting eIF4F-complex formation might be a novel therapeutic target in
Alzheimer’s disease
International Student Congress, ISC 2018; MAY 31- JUN 2, 2018; Graz, AUSTRIA. 2018.
[Poster]
Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Töglhofer, AM; Krassnig, S; Niedrist, T; Thalhammer, M; Aigelsreiter, A; Rose-John, S; Fickert, P; Rinner, B; Haybäck, J;
Die Rolle des Interleukin-6 Rezeptors im Zuge der Cholangiozellulären Karzinogenese.
Jahrestagung der Deutschen Gesellschaft für Pathologie. 2018; -102. Jahrestagung der DGP; MAI 24-28, 2018; Berlin.
[Poster]
Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Töglhofer, AM; Krassnig, S; Niedrist, T; Thalhammer, M; Aigelsreiter, A; Rose-John, S; Fikert, P; Rinner, B; Haybäck, J;
Classic and Trans Interleukin-6 Signaling Promotes Cholangiocarcinoma
6th International Students Congress. 2018; -6th International Students Congress; MAY 31 - JUNE 2; Graz, AUSTRIA.
[Oral Communication]
Krassnig, S; Baehr, A; Schinlauer, A; Golob-Schwarzl, N; Wodlej, C; Raicht, A; Speicher, I; Poehlmann-Nitsche, A; Asslaber, M; Mawrin, C; Benesch, M; Haybaeck, J
Expression levels of eukaryotic initation factors are altered in paediatric medulloblastoma
Der Pathologe 39: 89-89. 2018; -102. Jahrestagung der Deutschen Gesellschaft für Pathologie; MAY 24-26, 2018; Berlin, GERMANY.
[Oral Communication]
FullText
Riedl, S; Rinner, B; Schaider, H; Liegl-Atzwanger, B; Wodlej, C; Grissenberger, S; Preishuber-Pflugl, J; Lohner, K; Zweytick, D
Fighting melanoma - human lactoferricin derived peptides kill cancer cells by inducing severe stress and apoptosis
J PEPT SCI. 2018; 24: S140-S141.
[Poster]
Web of Science
Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Herzl, A; Kleinegger, F; Birkl-Toeglhofer, AM; Gantenbein, N; Speicher, I; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J;
Die Rolle von eukaryotischen Translations-Initiationsfaktoren als potentielles neues therapeutisches Target beim Neuroblastom
Der Pathologe 39: 94-94. 2018; -102. Jahrestagung der Deutschen Gesellschaft für Pathologie; MAY 24-26,2018; Berlin, GERMANY.
[Oral Communication]
FullText
Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Birkl-Toeglhofer, AM; Herzl, A; Singer, G; Toll, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J
Eukaryotic Initiation Factor 4A1 as Potential Therapeutic Target in Neuroblastoma
Proceedings of the Doctoral Day. 2018; -Doctoral Day 2018; NOV 28, 2018; Graz, AUSTRIA.
[Poster]
Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Toeglhofer, AM; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Hayback, J
The Role of Eukaryotic Translation Initiation Factors as Potential Targets in Neuroblastoma
ONCOL RES TREAT. 2018; 41: 131-131.-33. Deutscher Krebs Kongress; FEB, 21-24, 2018; Berlin, GERMANY.
[Poster]
Web of Science
Golob-Schwarzl, N; Krassnig, S; Park, Y; Gogg-Kamerer, M; Wodlej, C; Vierlinger, K; Schroeder, F; Rhee, H; Schicho, R; Fickert, P; Haybaeck, J
PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors as new biomarkers in liver cancer
VIRCHOWS ARCH. 2017; 471: S164-S164.
[Poster]
Web of Science
Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Toeglhofer, AM; Baran, P; Krassnig, S; Niedrist, T; Rinner, B; Thalhammer, M; Aigelsreiter, A; Scheller, J; Rose-John, S; Fickert, P; Haybaeck, J;
The Role of Interleukin-6 Receptor Signaling in Cholangiocarcinoma
Proceedings of the Doctoral Day. 2017; -Proceedings of the Doctoral Day.; DEC 13, 2017; Graz, Austria.
[Poster]
Krassnig, S; Orthmann, A; Toeglhofer, AM; Wohlrab, C; Golob-Schwarzl, N; Wodlej, C; Pennauer, M; Raicht, A; Ali, KM; von Campe, G; Gogg-Kamerer, M; Logi, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors might not only represent novel targets for glioma therapies but might also monitor drug effectiveness
VIRCHOWS ARCH. 2017; 471: S46-S46.
[Oral Communication]
Web of Science
Krassnig, S; Toeglhofer, AM; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Sygulla, S; Leoni, M; Weis, S; Haybaeck, J;
Alterations in the expression levels of eukaryotic initiation factors in Alzheimer’s disease
Der Pathologe Ausgabe 5/2017. 2017; -Herbsttagung der ÖGPath/IAP 2017; SEP 14-16, 2017; Velden, AUSTRIA.
[Poster]
Krassnig, S; Toeglhofer, AM; Golob-Schwarzl, N; Wodlej, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J
Eukaryotic initiation factor 4G (eIF4G) is altered in Alzheimer’s disease and might therefore be involved in pathological mechanisms
Proceedings of the 13th International Conference on Alzheimer's and Parkinson's Diseases.. 2017; -13th International Conference on Alzheimer's and Parkinson's Diseases; MAR 29-APR 2; Vienna, AUSTRIA.
[Poster]
Krassnig, S; Wohlrab, C; Orthmann, A;Golob-Schwarzl, N; Toeglhofer, A; Wodlej, C; Pennauer, M; Raicht, A; Mahdy Ali, M; Von Campe, G; Leoni, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J .
Eukaryotische Initiationsfaktoren stellen ein potenzielles neues therapeutisches Target für die Behandlung von Gliomen dar
101. Jahrestagung der deutschen Gesellschaft für Pathologie ; JUN 22-24; Erlangen, GERMANY. 2017.
[Poster]
Krassnig, S;Orthmann, A; Wohlrab, C; Golob-Schwarzl, N; Toeglhofer, A; Wodlej, C; Pennauer, M; Raicht, A; Mahdy Ali, M; Von Campe, G; Gogg-Kamerer, M; Leoni, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors might represent a novel marker to monitor the effectiveness of glioma therapy.
Brain Tumor Meeting 2017; May 18-19, 2017; Berlin, GERMANY. 2017.
[Poster]
Riedl, S; Rinner, B; Schaider, H; Liegl-Atzwanger, B; Wodlej, C; Lohner, K; Zweytick, D
Human lactoferricin derived peptides trigger apoptosis in malignant melanoma in vitro and in vivo
EUR BIOPHYS J BIOPHY. 2017; 46: S390-S390.-19th IUPAB Congress / 11th EBSA Congress; JUL 16-20, 2017; British Biophys Soc, Edinburgh, SCOTLAND.
[Poster]
Web of Science
Riedl, S; Rinner, B; Schaider, H; Liegl-Atzwanger, B; Wodlej, C; Lohner, K; Zweytick, D
Human Lactoferricin Derived Peptides Induce Apoptosis Specifically in Cancer Cells through Targeting Membranous Phosphatidylserine
BIOPHYS J. 2017; 112(3):185A-185A.-61st Annual Meeting of the Biophysical-Society; FEB 11-15, 2017; New Orleans, LA.
Doi: 10.1016/j.bpj.2016.11.1027
[Poster]
Web of Science
FullText
FullText_MUG
Toeglhofer AM, Krassnig S, Golob-Schwarzl N, Kalev O, Leoni M, Wodlej C, Weis S, Haybaeck J
Alterations in eukaryotic translation initiation might contribute to Parkinson’s disease pathology
Proceedings of the 13th International Conference on Alzheimer's and Parkinson's Diseases. 2017; -13th International Conference on Alzheimer's and Parkinson's Diseases; MAR 29-APR 2; Vienna, AUSTRIA.
[Poster]
Toeglhofer, AM; Krassnig, S; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J
Eukaryotic initiation factors are altered in Alzheimer's disease
VIRCHOWS ARCH. 2017; 471: S218-S219.
[Poster]
Web of Science
Toeglhofer, AM; Krassnig, S; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J;
Eukaryotic initiation factors are altered in Alzheimer’s disease.
Proceedings of the 29th European Congress of Pathology. 2017; -29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, THE NETHERLANDS.
[Poster]
Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Birkl-Toeglhofer, AM; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J
Eukaryotic Translation Initiation Factors and Their Potential Role as Targets in Neuroblastoma
Proceedings of the Doctoral Day. 2017; -Doctoral Day; 13.12.2017; Graz, AUSTRIA.
[Poster]
Wodlej, C; Krassnig,S; Golob-Schwarzl, N; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J
Eukaryotic Translation Initiation Factors Might Represent Novel Targets in Neuroblastoma
International Student Congress (ISC); MAY 25-27, 2017; Graz, AUSTRIA. 2017.
[Oral Communication]